ECM
ALDR
Endurant Capital Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-91,600
| Closed | -$1.12M | – | 102 |
|
|
2017
Q3 | $1.12M | Buy |
91,600
+49,300
| +117% | +$604K | 0.34% | 63 |
|
|
2017
Q2 | $484K | Buy |
42,300
+5,600
| +15% | +$64.1K | 0.14% | 86 |
|
|
2017
Q1 | $763K | Buy |
+36,700
| New | +$763K | 0.25% | 72 |
|
|
2016
Q4 | – | Sell |
-19,500
| Closed | -$639K | – | 101 |
|
|
2016
Q3 | $639K | Buy |
19,500
+9,700
| +99% | +$318K | 0.24% | 67 |
|
|
2016
Q2 | $245K | Buy |
+9,800
| New | +$245K | 0.08% | 85 |
|